Literature DB >> 22314553

Correlation between clinical outcomes and appropriateness grading for referral to myocardial perfusion imaging for preoperative evaluation prior to non-cardiac surgery.

Angela S Koh1, Jennifer L S Flores, Felix Y J Keng, Ru San Tan, Terrance S J Chua.   

Abstract

BACKGROUND: In a previous study, we have found that referral to myocardial perfusion imaging(MPI) for preoperative evaluation of patients before non-cardiac surgery was the most common cause of inappropriate referral based on AHA/ACC Appropriate Use Guidelines, though 40% of scans graded as inappropriate had abnormal MPI results. The aim of this study was to correlate appropriateness grading with (1) the outcome of MPI scans, and (2) the clinical outcome of patients after surgery, so as to determine if the predictive value of MPI was related to appropriateness grading.
METHODS: All consecutive patients referred to the MPI laboratory of our center from March 2009 to July 2009 for preoperative risk stratification were prospectively studied. Patients’ medical records and stress data were collected, and all imaging results were recorded. Based on appropriate use criteria (AUC), MPI studies were classified into appropriate, inappropriate, uncertain or unclassified. MPI studies were classified on the basis of their results into normal or abnormal scans. Primary clinical outcome measured was the occurrence of any major cardiac and cerebrovascular event during follow-up up to 90 days.
RESULTS: There were 176 referrals for preoperative evaluation. 39.8% (n 5 70) of these referrals were graded as inappropriate. Based on AUC, referrals for MPI in intermediate- and high-risk groups with poor functional class were graded as appropriate, while referrals for MPI in low-risk and intermediate risk groups with normal functional class were graded as inappropriate referrals. The overall event rate was 6.25%. Cumulative death rate at 90 days was 1.7%, non-fatal MI 4%, and occurrence of stroke occurred in 0.6%. The primary outcome was higher in the intermediate group with poor functional class (13%) and high-risk group (64%) than the low-risk and intermediate risk groups with good functional class (4%). In the high-risk group, an abnormal MPI scan was associated with an extremely high event rate (50%) that was significantly greater than the event rate in patients with a normal MPI result (14%) (P 5 .01). Although 40% of preoperative low-risk and intermediate risk patients had an abnormal MPI result, their over all event rates were low (0 and 4%, respectively), with no difference in the rate of events between patients with normal and abnormal MPI scans in the inappropriate group.
CONCLUSIONS: In conclusion, in correlating the relationship between appropriateness grading by AUC with the outcome of MPI scans and subsequent event rates, we found that MPI results predicted outcome in appropriately tested patients, but not in patients whose tests were classified as inappropriate, in whom event rates were low, regardless of the results of testing. Our findings support the AUC recommendations for the selective role of testing in preoperative risk stratification,which use the type of surgery and functional class to determine the appropriateness of referral.

Entities:  

Mesh:

Year:  2012        PMID: 22314553     DOI: 10.1007/s12350-011-9462-0

Source DB:  PubMed          Journal:  J Nucl Cardiol        ISSN: 1071-3581            Impact factor:   5.952


  14 in total

1.  Derivation and prospective validation of a simple index for prediction of cardiac risk of major noncardiac surgery.

Authors:  T H Lee; E R Marcantonio; C M Mangione; E J Thomas; C A Polanczyk; E F Cook; D J Sugarbaker; M C Donaldson; R Poss; K K Ho; L E Ludwig; A Pedan; L Goldman
Journal:  Circulation       Date:  1999-09-07       Impact factor: 29.690

2.  Should major vascular surgery be delayed because of preoperative cardiac testing in intermediate-risk patients receiving beta-blocker therapy with tight heart rate control?

Authors:  Don Poldermans; Jeroen J Bax; Olaf Schouten; Aleksandar N Neskovic; Bernard Paelinck; Guido Rocci; Laura van Dortmont; Anai E S Durazzo; Louis L M van de Ven; Marc R H M van Sambeek; Miklos D Kertai; Eric Boersma
Journal:  J Am Coll Cardiol       Date:  2006-08-17       Impact factor: 24.094

3.  ACC/AHA 2007 guidelines on perioperative cardiovascular evaluation and care for noncardiac surgery: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery): developed in collaboration with the American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Rhythm Society, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, and Society for Vascular Surgery.

Authors:  Lee A Fleisher; Joshua A Beckman; Kenneth A Brown; Hugh Calkins; Elliott Chaikof; Kirsten E Fleischmann; William K Freeman; James B Froehlich; Edward K Kasper; Judy R Kersten; Barbara Riegel; John F Robb; Sidney C Smith; Alice K Jacobs; Cynthia D Adams; Jeffrey L Anderson; Elliott M Antman; Christopher E Buller; Mark A Creager; Steven M Ettinger; David P Faxon; Valentin Fuster; Jonathan L Halperin; Loren F Hiratzka; Sharon A Hunt; Bruce W Lytle; Rick Nishimura; Joseph P Ornato; Richard L Page; Lynn G Tarkington; Clyde W Yancy
Journal:  Circulation       Date:  2007-09-27       Impact factor: 29.690

4.  A clinical randomized trial to evaluate the safety of a noninvasive approach in high-risk patients undergoing major vascular surgery: the DECREASE-V Pilot Study.

Authors:  Don Poldermans; Olaf Schouten; Radosav Vidakovic; Jeroen J Bax; Ian R Thomson; Sanne E Hoeks; Harm H H Feringa; Martin Dunkelgrün; Peter de Jaegere; Alexander Maat; Marc R H M van Sambeek; Miklos D Kertai; Eric Boersma
Journal:  J Am Coll Cardiol       Date:  2007-04-16       Impact factor: 24.094

5.  ACCF/ASNC/ACR/AHA/ASE/SCCT/SCMR/SNM 2009 Appropriate Use Criteria for Cardiac Radionuclide Imaging: A Report of the American College of Cardiology Foundation Appropriate Use Criteria Task Force, the American Society of Nuclear Cardiology, the American College of Radiology, the American Heart Association, the American Society of Echocardiography, the Society of Cardiovascular Computed Tomography, the Society for Cardiovascular Magnetic Resonance, and the Society of Nuclear Medicine.

Authors:  Robert C Hendel; Daniel S Berman; Marcelo F Di Carli; Paul A Heidenreich; Robert E Henkin; Patricia A Pellikka; Gerald M Pohost; Kim A Williams
Journal:  J Am Coll Cardiol       Date:  2009-06-09       Impact factor: 24.094

6.  Application of appropriateness criteria to stress single-photon emission computed tomography sestamibi studies and stress echocardiograms in an academic medical center.

Authors:  Raymond J Gibbons; Todd D Miller; David Hodge; Lynn Urban; Philip A Araoz; Patricia Pellikka; Robert B McCully
Journal:  J Am Coll Cardiol       Date:  2008-04-01       Impact factor: 24.094

7.  Dipyridamole-thallium scintigraphy and gated radionuclide angiography to assess cardiac risk before abdominal aortic surgery.

Authors:  J F Baron; O Mundler; M Bertrand; E Vicaut; E Barré; G Godet; C M Samama; P Coriat; E Kieffer; P Viars
Journal:  N Engl J Med       Date:  1994-03-10       Impact factor: 91.245

8.  Meta-analysis of intravenous dipyridamole-thallium-201 imaging (1985 to 1994) and dobutamine echocardiography (1991 to 1994) for risk stratification before vascular surgery.

Authors:  L J Shaw; K A Eagle; B J Gersh; D D Miller
Journal:  J Am Coll Cardiol       Date:  1996-03-15       Impact factor: 24.094

9.  Preoperative dipyridamole thallium imaging and ambulatory electrocardiographic monitoring as a predictor of perioperative cardiac events and long-term outcome.

Authors:  L A Fleisher; S H Rosenbaum; A H Nelson; D Jain; F J Wackers; B L Zaret
Journal:  Anesthesiology       Date:  1995-11       Impact factor: 7.892

10.  Finding value in imaging: what is appropriate?

Authors:  Raymond J Gibbons
Journal:  J Nucl Cardiol       Date:  2008 Mar-Apr       Impact factor: 3.872

View more
  13 in total

1.  The limitations of small outcome studies.

Authors:  Raymond J Gibbons; David Hodge
Journal:  J Nucl Cardiol       Date:  2012-04       Impact factor: 5.952

2.  Pitfalls in statistical methods.

Authors:  Mario Petretta; Alberto Cuocolo
Journal:  J Nucl Cardiol       Date:  2012-08       Impact factor: 5.952

3.  Reply: Correlation between clinical outcomes and appropriateness grading for referral to myocardial perfusion imaging for preoperative evaluation prior to non-cardiac surgery.

Authors:  Angela S Koh; Terrance Chua
Journal:  J Nucl Cardiol       Date:  2013-03-09       Impact factor: 5.952

4.  Reply: Logistic regression, odds ratio, and factor variables.

Authors:  Mario Petretta; Alberto Cuocolo
Journal:  J Nucl Cardiol       Date:  2013-08       Impact factor: 5.952

5.  Clinical utility of inappropriate positron emission tomography myocardial perfusion imaging: test results and cardiovascular events.

Authors:  David E Winchester; Ryan J Chauffe; Ryan Meral; Daniel Nguyen; Scott Ryals; Raman Dusaj; Leslee Shaw; Rebecca J Beyth
Journal:  J Nucl Cardiol       Date:  2014-08-02       Impact factor: 5.952

6.  The value and appropriateness of positron emission tomography: an evolving tale.

Authors:  Robert C Hendel
Journal:  J Nucl Cardiol       Date:  2014-08-23       Impact factor: 5.952

7.  ASNC imaging guidelines for nuclear cardiology procedures : Standardized reporting of nuclear cardiology procedures.

Authors:  Peter L Tilkemeier; Jamieson Bourque; Rami Doukky; Rupa Sanghani; Richard L Weinberg
Journal:  J Nucl Cardiol       Date:  2017-09-15       Impact factor: 5.952

Review 8.  Effective risk stratification of patients on the basis of myocardial perfusion SPECT is dependent on appropriate patient selection.

Authors:  Sarah Alexander; Rami Doukky
Journal:  Curr Cardiol Rep       Date:  2015-01       Impact factor: 2.931

Review 9.  The comparative and added prognostic value of biomarkers to the Revised Cardiac Risk Index for preoperative prediction of major adverse cardiac events and all-cause mortality in patients who undergo noncardiac surgery.

Authors:  Lisette M Vernooij; Wilton A van Klei; Karel Gm Moons; Toshihiko Takada; Judith van Waes; Johanna Aag Damen
Journal:  Cochrane Database Syst Rev       Date:  2021-12-21

Review 10.  Outcomes after inappropriate nuclear myocardial perfusion imaging: A meta-analysis.

Authors:  Islam Y Elgendy; Ahmed Mahmoud; Jonathan J Shuster; Rami Doukky; David E Winchester
Journal:  J Nucl Cardiol       Date:  2015-08-08       Impact factor: 5.952

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.